+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Combination of Oxaliplatin and Vit.E-TPGS in Lipid Nanosystem for Enhanced Therapeutic Efficacy in Colon Cancers

Combination of Oxaliplatin and Vit.E-TPGS in Lipid Nanosystem for Enhanced Therapeutic Efficacy in Colon Cancers

Pharmaceutical Research 35(2): 27

The main aim of present study was to prepare the oxaliplatin (OXL)-loaded D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS)-based lipid nanoparticles to enhance the anticancer effect in colon cancer cells. The nanoparticles were nanosized and spherical shaped and exhibited controlled release kinetics. Flow cytometer and confocal laser scanning microscopy (CLSM) showed a remarkable uptake of nanoparticles in cancer cells in a time-dependent manner. The presence of TPGS remarkably increased the anticancer effect of OXL in HT-29 colon cancer cells. The IC50 value of free OXL was 4.25 μg/ml whereas IC50 value of OXL-loaded TPGS-based lipid nanoparticles (OXL/TLNP) was 1.12 μg/ml. The 3-fold lower IC50 value of OXL/TLNP indicates the superior anticancer effect of nanoparticle-based OXL. Consistently, OXL/TLNP induced a remarkable apoptosis of cancer cells. Approximately, ~52% of cells were in early apoptosis phase and ~13% of cells were in late apoptosis phase indicating the potent anticancer effect of the formulations. The findings from this study provide novel insights into the use of TPGS and lipid nanoparticle together for the better antitumor effect in colon cancers. Future studies will involve the detailed in vitro and in vivo studies on clinically relevant animals.

(PDF emailed within 0-6 h: $19.90)

Accession: 055282524

Download citation: RISBibTeXText

PMID: 29368145

DOI: 10.1007/s11095-017-2297-x

Related references

Capsaicin-loaded folic acid-conjugated lipid nanoparticles for enhanced therapeutic efficacy in ovarian cancers. Biomedicine and PharmacoTherapy 91: 999-1005, 2017

HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers. Journal of Drug Targeting 2018: 1-30, 2018

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers. Anti-Cancer Drugs 8(9): 876-885, 1997

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer. Cancer Treatment Reviews 30(8): 711-713, 2004

Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model. Cancer Science 108(9): 1864-1869, 2017

Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers. Bmc Cancer 15: 504, 2016

Selective delivery of oxaliplatin to tumor tissue by nanocarrier system enhances overall therapeutic efficacy of the encapsulated oxaliplatin. Biological and Pharmaceutical Bulletin 37(2): 206-211, 2014

Combinations of calmodulin antagonists with fu and fdurd in human colon cancers in vitro efficacy and therapeutic indices. Proceedings of the American Association for Cancer Research Annual Meeting 29: 481, 1988

Therapeutic efficacy of vitamin D-3-binding protein-derived macrophage activating factor for prostate, breast and colon cancers. Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 31, 1997

Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells. Human Gene Therapy 17(12): 1241-1253, 2006

Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers. International Journal of Nanomedicine 13: 4379-4389, 2018

Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and localized hyperthermia. Breast Cancer Research & Treatment 8(1): 91, 1986

Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel. Colloids and Surfaces. B, Biointerfaces 123: 716-723, 2015

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers. Cancer Gene Therapy 13(3): 253-265, 2005

Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2. Clinical & Experimental Metastasis. 12(6): 368-374, 1994